Human Events Daily host Jack Posobiec spoke Wednesday with Dr. Alejandro Díaz about Robert F. Kennedy Jr.’s decision to terminate federal contracts tied to mRNA vaccine research.
Posobiec asked why Kennedy moved so decisively to end the program. “I’ve heard about the issues with mRNA,” he said, “but why was it specifically that RFK Jr. came in and said, we’re canceling this, it’s terminated?”
Dr. Díaz responded, “You know, Jack, what I can tell you is that this is bad news for a few, but great news for the rest of the world. You know, as an immunologist and very actively and an active voice internationally during the initiation of the COVID operation, I was against this mass vaccination because that was an experimental vaccine. And now we know, unfortunately, the damage it’s already done.”
Díaz praised Kennedy, along with NIH Director Dr. Jay Bhattacharya, saying, “What I admire and deeply admire about Secretary Robert F. Kennedy Jr., as well as Director of NIH, Dr. J. Bhattacharya, is that they promise to make America healthy again through the MAHA movement. And that’s exactly what they are delivering. So I’m very proud of them. I am very proud of President Trump, and I am very proud of what they’re doing because that’s exactly what we need.”
He stressed that Kennedy is drawing limits on future research: “Secretary Kennedy, he wants to make sure that everybody understands that the research for mRNA, the research for mRNA will be only for upper respiratory viruses. And I think that’s an amazing, that’s an amazing decision. I’m very proud of him as an immunologist and obviously as a pediatrician.”
Posobiec pointed to the wave of criticism now coming from media and industry: “So when we look at this now, the response from Big Pharma, and anyone can just go see the headlines. The Wall Street Journal has a huge op-ed out saying RFK’s dangerous attack on mRNA research, Biopharma drive, Kennedy’s mRNA cuts could set U.S. science back, etc. Even the LA Times is coming out now, the BBC, NPR, they’re fact-checking him left and right, Washington Post. Are we seeing this big industry response because of the fact that he’s doing exactly what he said he would do on the campaign trail, and that he’s actually demanding that real studies be done before U.S. taxpayer money is going to this new technology?”
“That is exactly right, Jack,” Díaz replied. “And you know, he’s delivering what he promised, and I’m very supportive of him. I had a very deep conversation with him once through Zoom, and it’s amazing the amount of knowledge that he has in terms of medicine. He’s a lawyer, but I bet he knows, sometimes he knows more things than many of my colleagues.”
Díaz highlighted the scale of Kennedy’s move, noting, “So they took an amazing turn of canceling these 22 mRNA contracts worth nearly $500 million, and that’s something. That’s something. That’s why I say bad news for a few and great news for the rest of the world.”
Posobiec asked why Kennedy moved so decisively to end the program. “I’ve heard about the issues with mRNA,” he said, “but why was it specifically that RFK Jr. came in and said, we’re canceling this, it’s terminated?”
Dr. Díaz responded, “You know, Jack, what I can tell you is that this is bad news for a few, but great news for the rest of the world. You know, as an immunologist and very actively and an active voice internationally during the initiation of the COVID operation, I was against this mass vaccination because that was an experimental vaccine. And now we know, unfortunately, the damage it’s already done.”
Díaz praised Kennedy, along with NIH Director Dr. Jay Bhattacharya, saying, “What I admire and deeply admire about Secretary Robert F. Kennedy Jr., as well as Director of NIH, Dr. J. Bhattacharya, is that they promise to make America healthy again through the MAHA movement. And that’s exactly what they are delivering. So I’m very proud of them. I am very proud of President Trump, and I am very proud of what they’re doing because that’s exactly what we need.”
He stressed that Kennedy is drawing limits on future research: “Secretary Kennedy, he wants to make sure that everybody understands that the research for mRNA, the research for mRNA will be only for upper respiratory viruses. And I think that’s an amazing, that’s an amazing decision. I’m very proud of him as an immunologist and obviously as a pediatrician.”
Posobiec pointed to the wave of criticism now coming from media and industry: “So when we look at this now, the response from Big Pharma, and anyone can just go see the headlines. The Wall Street Journal has a huge op-ed out saying RFK’s dangerous attack on mRNA research, Biopharma drive, Kennedy’s mRNA cuts could set U.S. science back, etc. Even the LA Times is coming out now, the BBC, NPR, they’re fact-checking him left and right, Washington Post. Are we seeing this big industry response because of the fact that he’s doing exactly what he said he would do on the campaign trail, and that he’s actually demanding that real studies be done before U.S. taxpayer money is going to this new technology?”
“That is exactly right, Jack,” Díaz replied. “And you know, he’s delivering what he promised, and I’m very supportive of him. I had a very deep conversation with him once through Zoom, and it’s amazing the amount of knowledge that he has in terms of medicine. He’s a lawyer, but I bet he knows, sometimes he knows more things than many of my colleagues.”
Díaz highlighted the scale of Kennedy’s move, noting, “So they took an amazing turn of canceling these 22 mRNA contracts worth nearly $500 million, and that’s something. That’s something. That’s why I say bad news for a few and great news for the rest of the world.”
